{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:16:47Z","timestamp":1781533007337,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.leukres.2008.05.023","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T09:09:36Z","timestamp":1216372176000},"page":"39-45","source":"Crossref","is-referenced-by-count":45,"title":["Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia\/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity"],"prefix":"10.1016","volume":"33","author":[{"given":"Masato","family":"Hoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetsugu","family":"Fujigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Seishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.05.023_bib1","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1073\/pnas.77.11.6815","article-title":"T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2008.05.023_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","article-title":"Human T cell leukemia virus type I (HTLV-I) and human diseases","volume":"15","author":"Uchiyama","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.leukres.2008.05.023_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.05.023_bib4","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2008.05.023_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.1988.6.7.1088","article-title":"Major prognostic factors of adult patients with advanced T-cell lymphoma\/leukemia","volume":"6","author":"Shimoyama","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2008.05.023_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.05.023_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.05.023_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1097-0142(19930801)72:3<735::AID-CNCR2820720317>3.0.CO;2-O","article-title":"Spontaneous regression in adult T-cell leukemia\/lymphoma","volume":"72","author":"Shimamoto","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.05.023_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-2133.2001.04053.x","article-title":"Spontaneous regression of cutaneous lesions in adult T-cell leukaemia\/lymphoma","volume":"144","author":"Kawabata","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2008.05.023_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000204089","article-title":"Observation of T cell surface antigens in the clinical course of adult T-cell leukemia: case report of a spontaneous remission","volume":"93","author":"Suzuki","year":"1995","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2008.05.023_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0925-5710(96)00564-6","article-title":"Cytotoxic activity in a case of adult T-cell leukemia\/lymphoma with spontaneous regression","volume":"65","author":"Jinnohara","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2008.05.023_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","article-title":"Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?","volume":"20","author":"Mellor","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.leukres.2008.05.023_bib13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.05.023_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.05.023_bib15","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.bjc.6600336","article-title":"Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer","volume":"86","author":"Huang","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2008.05.023_bib16","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S","article-title":"Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism","volume":"31","author":"Fujigaki","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2008.05.023_bib17","first-page":"699","article-title":"Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis, and adult T-cell leukemia\/lymphoma","volume":"5","author":"Giusti","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.leukres.2008.05.023_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/107999000312306","article-title":"Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently","volume":"20","author":"Currier","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.leukres.2008.05.023_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/jir.1997.17.387","article-title":"Potentiation of interferon-induced indoleamine 2,3-dioxygenase mRNA in human mononuclear phagocytes by lipopolysaccharide and interleukin-1","volume":"17","author":"Hissong","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.leukres.2008.05.023_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/jir.1995.15.617","article-title":"Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes","volume":"15","author":"Hu","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.leukres.2008.05.023_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1006\/cyto.1999.0661","article-title":"Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells","volume":"12","author":"Babcock","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.leukres.2008.05.023_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/107999003322277829","article-title":"Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha","volume":"23","author":"Robinson","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.leukres.2008.05.023_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jb\/mvj072","volume":"139","author":"Fujigaki","year":"2006","journal-title":"J Biochem"},{"key":"10.1016\/j.leukres.2008.05.023_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jir.2005.25.20","article-title":"The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase","volume":"25","author":"Robinson","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.leukres.2008.05.023_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/jir.1995.15.517","article-title":"Involvement of two regulatory elements in interferon-gamma-regulated expression of human indoleamine 2,3-dioxygenase gene","volume":"15","author":"Chon","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.leukres.2008.05.023_bib26","doi-asserted-by":"crossref","first-page":"17247","DOI":"10.1074\/jbc.271.29.17247","article-title":"Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene","volume":"271","author":"Chon","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.05.023_bib27","doi-asserted-by":"crossref","first-page":"13897","DOI":"10.1073\/pnas.94.25.13897","article-title":"Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins","volume":"94","author":"Takemoto","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2008.05.023_bib28","first-page":"2360","article-title":"Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells","volume":"93","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.05.023_bib29","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1128\/MCB.18.9.5157","article-title":"Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases","volume":"18","author":"Geleziunas","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2008.05.023_bib30","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","article-title":"Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia","volume":"106","author":"Watanabe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.05.023_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10428199609093442","article-title":"Features of the cytokines secreted by adult T cell leukemia (ATL) cells","volume":"21","author":"Yamada","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2008.05.023_bib32","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","article-title":"Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia","volume":"73","author":"Kamihira","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.05.023_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","article-title":"Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy","volume":"11","author":"Muller","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2008.05.023_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1593\/neo.04658","article-title":"Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer.","volume":"7","author":"Astigiano","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.leukres.2008.05.023_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1568010023344869","article-title":"The immunosuppressive activity of pro-inflammatory cytokines in experimental models: potential for therapeutic intervention in autoimmunity","volume":"1","author":"Grohmann","year":"2002","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.leukres.2008.05.023_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2567.2005.02224.x","article-title":"Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways","volume":"116","author":"Le Rond","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2008.05.023_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1533-869X.2003.01108.x","article-title":"Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth","volume":"3","author":"Kai","year":"2003","journal-title":"J Exp Therapeut Oncol"},{"key":"10.1016\/j.leukres.2008.05.023_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0300-9475.2004.01378.x","article-title":"Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells","volume":"59","author":"Kai","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.leukres.2008.05.023_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/348245a0","article-title":"Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease","volume":"348","author":"Jacobson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.05.023_bib40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-06-2925","article-title":"Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses","volume":"67","author":"Hou","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2008.05.023_bib41","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.4049\/jimmunol.177.8.5639","article-title":"Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference","volume":"177","author":"Zheng","year":"2006","journal-title":"J Immunol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T02:59:56Z","timestamp":1588820396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608002749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0145212608002749"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.05.023","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}